Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept Combined With Nasal Insulin to Preserve Beta-cell Function in Recently-diagnosed Type 1 Diabetes

NCT05742243 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT05742243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05742243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept Combined With Nasal Insulin to Preserve Beta-cell Function in Recently-diagnosed Type 1 Diabetes
Lead sponsor
Melbourne Health
Phase
Phase 2
Overall status
Completed
Start date
February 13, 2023
Completion date
September 30, 2025
Enrollment
68 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, type 1 diabetes